K173690 · Natus Medical Incorporated Dba Excel-Tech Ltd. (Xltek) · OLV · Mar 9, 2018 · Neurology
Device Facts
Record ID
K173690
Device Name
Grass TWin
Applicant
Natus Medical Incorporated Dba Excel-Tech Ltd. (Xltek)
Product Code
OLV · Neurology
Decision Date
Mar 9, 2018
Decision
SESE
Submission Type
Special
Regulation
21 CFR 882.1400
Device Class
Class 2
Attributes
Software as a Medical Device
Intended Use
This software is intended for use by qualified research and clinical professionals with specialized training in the use of EEG and PSG recording instrumentation for the digital recording, playback, and analysis of physiological signals. It is suitable for digital acquisition, display, comparison, analysis, and archiving of EEG potentials and other rapidly changing physiological parameters.
Device Story
Grass TWin is a software-only application for digital acquisition, display, analysis, and archiving of EEG and PSG physiological signals; used for Electroencephalography, Polysomnography, and Long-term Epilepsy Monitoring. Operated by qualified research and clinical professionals in clinical settings. Software interfaces with various Natus/XLTEK hardware recorders (e.g., AURA, Comet, SleepTrek3, Beehive Horizon). Input consists of physiological signals from compatible hardware; software processes these for visualization and review. Output includes digital waveforms and trends (e.g., Pulse Transit Time) displayed on a PC monitor. Clinicians use the output to interpret neurological and sleep-related data, supporting diagnostic and clinical decision-making. Benefits include efficient data management and analysis of rapidly changing physiological parameters.
Clinical Evidence
Bench testing only. No clinical data provided. Software verification and validation performed per IEC 62304, IEC 60601-1-6, and IEC 62366 standards. Results confirmed compliance with predetermined specifications and performance requirements.
Technological Characteristics
Software-only device; no hardware. Operates on Microsoft Windows 7 and Windows Server 2008. Connectivity via integration with Natus/XLTEK recording systems (AURA, Comet, SleepTrek3, Beehive Horizon). Features include PTT trend analysis and montage editor summation. Developed per IEC 62304 software life cycle processes.
Indications for Use
Indicated for qualified research and clinical professionals trained in EEG and PSG instrumentation for digital recording, playback, and analysis of physiological signals, including EEG potentials and other rapidly changing physiological parameters.
Regulatory Classification
Identification
An electroencephalograph is a device used to measure and record the electrical activity of the patient's brain obtained by placing two or more electrodes on the head.
K200878 — Natus NeuroWorks · Natus Medical Incorporated Dba Excel-Tech Ltd. (Xltek) · May 18, 2020
K081551 — TWIN NEUROTRAC-III · Astro-Med, Inc. · Dec 24, 2008
K012976 — TWIN PLUS · Grass-Telefactor Divison · Feb 12, 2002
K133995 — NEURON-SPECTRUM-4/P WITH NEURON-SPECTRUM.NET SOFTWARE · Neurosoft , Ltd. · Jun 19, 2015
Submission Summary (Full Text)
{0}------------------------------------------------
Image /page/0/Picture/0 description: The image contains the logos of the Department of Health & Human Services and the Food and Drug Administration (FDA). The Department of Health & Human Services logo is on the left, and the FDA logo is on the right. The FDA logo includes the letters "FDA" in a blue square, followed by the words "U.S. FOOD & DRUG ADMINISTRATION" in blue text.
Natus Medical Incorporated DBA Excel-Tech Ltd. (XLTEK) Shane Sawall Manager, Regulatory Affairs 2568 Bristol Circle Oakville, Ontario L6H 5S1 CA
March 9, 2018
### Re: K173690
Trade/Device Name: Grass TWin Regulation Number: 21 CFR 882.1400 Regulation Name: Electroencephalograph Regulatory Class: Class II Product Code: OLV, GWQ Dated: February 12, 2018 Received: February 14, 2018
Dear Shane Sawall:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
{1}------------------------------------------------
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
# Michael J. Hoffmann -S
Carlos Peña, Ph.D. for Director Division of Neurological and Physical Medicine Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
## Indications for Use
510(k) Number (if known) K173690
Device Name Grass® TWin®
#### Indications for Use (Describe)
This software is intended for use by qualified research and clinical professionals with specialized training in the use of EEG and PSG recording instrumentation for the digital recording, playback, and analysis of physiological signals. It is suitable for digital acquisition, display, comparison, and archiving of EEG potentials and other rapidly changing physiological parameters.
Type of Use (Select one or both, as applicable)
| <span style="font-size:10px">☒</span> Prescription Use (Part 21 CFR 801 Subpart D) | <span style="font-size:10px">☐</span> Over-The-Counter Use (21 CFR 801 Subpart C) |
|------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------|
|------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------|
#### CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
#### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
> Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
{3}------------------------------------------------
Image /page/3/Picture/0 description: The image shows the word "status" in a teal color. Below the word "status" is the word "neurology" in a dark color. The word "status" has a trademark symbol to the right of it.
510(K) SUMMARY
Page 1 of 4
| Submission Date: | 30 November 2017 | | |
|-----------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------|----------------------------------------------------------------------------------|
| Submitter: | Natus Medical Incorporated DBA Excel-Tech Ltd. (XLTEK)<br>2568 Bristol Circle<br>Oakville, Ontario, L6H 5S1<br>Canada | | |
| Submitter and<br>Application<br>Correspondent | Mr. Shane Sawall<br>Phone: +1 (608) 829-8673<br>Fax: +1 (608) 829-8771<br>Email: shane.sawall@natus.com | | |
| Manufacturing Site: | Natus Medical Incorporated DBA Excel-Tech Ltd. (XLTEK)<br>2568 Bristol Circle<br>Oakville, Ontario, L6H 5S1<br>Canada | | |
| Trade Name: | Grass® TWin® | | |
| Common and<br>Classification<br>Name: | Standard Polysomnograph With Electroencephalograph | | |
| Classification<br>Regulation: | 21 CFR §882.1400 | | |
| Product Code: | OLV, GWQ | | |
| Substantially<br>Equivalent Devices: | New Model | Predicate 510(k)<br>Number | Predicate<br>Manufacturer / Model |
| | XLTEK / Grass TWin | K012976 | Grass-Telefactor<br>Division, Astro-Med,<br>Inc. / Grass-Telefactor<br>TWin PLUS |
| Device Description: | The Natus Medical Incorporated (Natus) DBA Excel-Tech Ltd.<br>(XLTEK) Grass® TWin ® (Grass TWin) is a comprehensive software<br>program intended for Electroencephalography (EEG), Polysomnography<br>(PSG), and Long-term Epilepsy Monitoring (LTM). TWin is incredibly<br>powerful and flexible, but also designed for easy and efficient day-to-day<br>use. Grass TWin is a software product only, and does not include any<br>hardware. | | |
{4}------------------------------------------------
Image /page/4/Picture/0 description: The image contains the logo for Natus Neurology. The word "natus" is written in a teal sans-serif font, with a small registered trademark symbol to the right of the word. Below "natus", the word "neurology" is written in a dark blue sans-serif font.
Technology
Comparison:
This software is intended for use by qualified research and clinical Intended Use: professionals with specialized training in the use of EEG and PSG recording instrumentation for the digital recording, playback, and analysis of physiological signals. It is suitable for digital acquisition, display, comparison, analysis, and archiving of EEG potentials and other rapidly changing physiological parameters.
> The Grass TWin employs the same technological characteristics as the predicate device.
| System Characteristic | Grass-Telefactor Division,<br>Astro-Med, Inc.<br>Grass-Telefactor TWin PLUS<br>(K012976) | XLTEK Grass TWin<br>(Proposed Device) |
|------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------|
| Intended Use | This software is intended for use<br>by qualified research and clinical<br>professionals with specialized<br>training in the use of EEG and<br>PSG recording instrumentation<br>for the digital recording.<br>playback, and analysis of<br>physiological signals. It is<br>suitable for digital acquisition,<br>display, comparison, analysis, and<br>archiving of EEG potentials and<br>other rapidly changing<br>physiological parameters. | Same. |
| Personal Computer<br>Operating System | Microsoft® Windows 98 or 2000 | Microsoft® Windows 7 and<br>Windows Server 2008 |
| Recording System<br>Compatibility | AURA PSG Wireless/Ambulatory<br>Recorder | AURA PSG Wireless/Ambulatory<br>Recorder |
| | AURA PSG Lite<br>Ambulatory/Wireless Sleep<br>Screener | AURA PSG Lite<br>Ambulatory/Wireless Sleep<br>Screener |
| | SleepTrek3 Portable Sleep<br>Screener | SleepTrek3 Portable Sleep<br>Screener |
| | Comet Series PSG | Comet and Comet-PLUS Series<br>PSG |
| | Comet Series EEG | Comet and Comet-PLUS Series<br>EEG |
| | AURA24 Ambulatory EEG | AURA24 Ambulatory EEG |
| | TREA Ambulatory EEG | TREA Ambulatory EEG |
| | Beehive Horizon for Long-Term<br>Monitoring | Beehive Horizon for Long-Term<br>Monitoring |
| Pulse Transit Time<br>(PTT) Trend Option | No | Yes |
| Montage Editor<br>Summation Feature | No | Yes |
{5}------------------------------------------------
Image /page/5/Picture/0 description: The image contains the logo for Natus Neurology. The word "natus" is in a larger, teal-colored font, while the word "neurology" is in a smaller, black font and is positioned below and to the right of "natus". The logo is simple and modern, with a clean design.
510(K) SUMMARY
Summary of Performance Testing:
Software
The Grass TWin software was designed and developed according to a robust software development process, and was rigorously verified and validated. Software information is provided in accordance with internal requirements and the following FDA guidance documents and standards:
- . The content of premarket submissions for software contained in medical devices, 11 May 05.
- Off-the-shelf software use in medical devices, 09 Sep 99. ●
- General principles of software validation; Final guidance for industry . and FDA staff, 11 Jan 02.
- Content of premarket submissions for management of cybersecurity in medical devices, 02 Oct 14.
- . Cybersecurity for networked medical devices containing off-the-shelf (OTS) software, 14 Jan 05
- . IEC 62304: 2006, Medical device software – Software life cycle processes
Results indicate that the Grass TWin software complies with its predetermined specifications, the applicable guidance documents, and the applicable standards.
Performance Testing - Bench The Grass TWin was verified for performance in accordance with internal requirements and the applicable clauses of the following standards:
- . IEC 60601-1-6: 2010, Am1: 2013, Medical electrical equipment -Part 1-6: General requirements for basic safety and essential performance – Collateral standard: Usability
- . IEC 62366: 2007, Am1: 2014, Medical devices – Application of usability engineering to medical devices.
Results indicate that the Grass TWin complies with its predetermined specifications and the applicable standards.
{6}------------------------------------------------
Image /page/6/Picture/0 description: The image contains the logo for Natus Neurology. The word "natus" is in a teal sans-serif font, with a registered trademark symbol next to it. Below that, the word "neurology" is in a smaller, italicized, dark blue font.
510(K) SUMMARY
PAGE 4 of 4
Verification and validation activities were conducted to establish the Conclusion performance and safety characteristics of the device modifications made to the Grass TWin. The results of these activities demonstrate that the Grass TWin is as safe, as effective, and performs as well as or better than the predicate devices.
> Therefore, the Grass TWin is considered substantially equivalent to the predicate devices.
Panel 1
/
Sort by
Ready
Predicate graph will load when search results are available.
Embedding visualization will load when search results are available.
PDF viewer will load when search results are available.
Loading panels...
Select an item from Submissions
Click any panel, subpart, regulation, product code, or device to see details here.
Section Matches
Results will appear here.
Product Code Matches
Results will appear here.
Special Control Matches
Results will appear here.
Loading collections...
Loading
My Alerts
You will receive email notifications based on the filters and frequency you set for each alert.
Sort by:
Create Alert
Search Filters
Agent Token
Create a read-only bearer token for Claude, ChatGPT, or other agents that can call HTTP APIs.